AAAAAA

   
Results: 1-17 |
Results: 17
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis
Authors: Colle, I Moreau, R Pessione, F Rassiat, E Heller, J Chagneau, C Pateron, D Barriere, E Condat, B Sogni, P Valla, D Lebrec, D
Citation: I. Colle et al., Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis, EUR J GASTR, 13(3), 2001, pp. 251-256
Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: Beneficial effects of a non-steroidal anti-inflammatory drugcoupled with a nitric oxide donor
Authors: Lefilliatre, P Sogni, P Bertrand, V Del Soldato, P Pateron, D Moreau, R Lebrec, D
Citation: P. Lefilliatre et al., Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: Beneficial effects of a non-steroidal anti-inflammatory drugcoupled with a nitric oxide donor, J GASTR HEP, 16(1), 2001, pp. 70-78
Mitochondrial toxic effects and ribavirin
Authors: Salmon-Ceron, D Chauvelot-Moachon, L Abad, S Silbermann, B Sogni, P
Citation: D. Salmon-ceron et al., Mitochondrial toxic effects and ribavirin, LANCET, 357(9270), 2001, pp. 1803-1804
Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose
Authors: Moreau, R Chagneau, C Heller, J Chevenne, D Langlet, P Deltenre, P Hillaire, S Lefilliatre, P Pateron, D Sogni, P Valla, D Lebrec, D
Citation: R. Moreau et al., Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose, SC J GASTR, 36(3), 2001, pp. 303-308
Hepatitis E-associated subacute liver failure: A rare indication for livertransplantation
Authors: Nicoluzzi, J Mennecier, D Sogni, P Soubrane, O Chaussade, S Cardoso, J Calmus, Y
Citation: J. Nicoluzzi et al., Hepatitis E-associated subacute liver failure: A rare indication for livertransplantation, AM J GASTRO, 96(7), 2001, pp. 2278-2279
Synopsis: Treatment of gastrointestinal bleeding in patients with cirrhosis
Authors: Sogni, P
Citation: P. Sogni, Synopsis: Treatment of gastrointestinal bleeding in patients with cirrhosis, GASTRO CL B, 24(1), 2000, pp. 97-103
Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
Authors: Heller, J Sogni, P Barriere, E Tazi, KA Chauvelot-Moachon, L Guimont, MC Bories, PN Poirel, O Moreau, R Lebrec, D
Citation: J. Heller et al., Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis, J HEPATOL, 33(3), 2000, pp. 376-381
The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension
Authors: Chagneau, C Tazi, KA Heller, J Sogni, P Poirel, O Moreau, R Lebrec, D
Citation: C. Chagneau et al., The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension, J HEPATOL, 33(1), 2000, pp. 26-32
Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilationof portal hypertension
Authors: Pateron, D Tazi, KA Sogni, P Heller, J Chagneau, C Poirel, O Philippe, M Moreau, R Lebrec, D
Citation: D. Pateron et al., Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilationof portal hypertension, GASTROENTY, 119(1), 2000, pp. 196-200
Nitric oxide, vasodilatation and cirrhosis: a double (im)balance
Authors: Sogni, P Moreau, R Lebrec, D
Citation: P. Sogni et al., Nitric oxide, vasodilatation and cirrhosis: a double (im)balance, GASTRO CL B, 23(1), 1999, pp. 101-104
Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration
Authors: Heller, J Sogni, P Tazi, KA Chagneau, C Poirel, O Moreau, R Lebrec, D
Citation: J. Heller et al., Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration, HEPATOLOGY, 30(3), 1999, pp. 698-704
Elevated circulating cardiac troponin I in patients with cirrhosis
Authors: Pateron, D Beyne, P Laperche, T Logeard, D Lefilliatre, P Sogni, P Moreau, R Langlet, P Elman, A Bernuau, J Valla, D Erlinger, S Lebrec, D
Citation: D. Pateron et al., Elevated circulating cardiac troponin I in patients with cirrhosis, HEPATOLOGY, 29(3), 1999, pp. 640-643
Endotoxemia: an unnecessary but aggravating condition in portal hypertension?
Authors: Sogni, P Moreau, R Lebrec, D
Citation: P. Sogni et al., Endotoxemia: an unnecessary but aggravating condition in portal hypertension?, J HEPATOL, 30(6), 1999, pp. 1160-1162
Vascular nitric oxide production during the development of two experimental models of portal hypertension
Authors: Gadano, AC Sogni, P Heller, J Moreau, R Bories, PN Lebrec, D
Citation: Ac. Gadano et al., Vascular nitric oxide production during the development of two experimental models of portal hypertension, J HEPATOL, 30(5), 1999, pp. 896-903
Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis
Authors: Pateron, D Oberti, F Lefilliatre, P Veal, N Tazi, KA Sogni, P Poirel, O Heller, J Moreau, R Cales, P Lebrec, D
Citation: D. Pateron et al., Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis, CLIN SCI, 97(3), 1999, pp. 313-318
Screening for hepatic iron overload.
Authors: Sogni, P
Citation: P. Sogni, Screening for hepatic iron overload., SEM HOP PAR, 75(17-18), 1999, pp. 540-547
In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis
Authors: Moreau, R Oberti, F Lahaye, P Gadano, A Cailmail, S Sogni, P Cales, P Lebrec, D
Citation: R. Moreau et al., In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis, J GASTR HEP, 13(12), 1998, pp. 1254-1258
Risultati: 1-17 |